Human regulatory T Cells are targets for human immunodeficiency virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain

Journal of Virology

Volumn 83, Issue 24, 2009, Pages 12925-12933

  Moreno Fernandez, Maria E ^a   Zapata, Wildeman ^a,b   Blackard, Jason T ^a   Franchini, Genoveffa ^c   Chougnet, Claire A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; LABORATORY; LIFE CYCLE; MALE; MOLECULAR DYNAMICS; PATHOGENESIS; PLANT GROWTH; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN;

DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIV CORE PROTEIN P24; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, CCR5; RECEPTORS, CXCR4; T-LYMPHOCYTES, REGULATORY; VIRUS REPLICATION;

ERAGROSTIS TEF; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 72849144975     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01352-09     Document Type: Article

References (36)

1. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78:2454-2459. (Pubitemid 38228938)
2. Andersson, J., A. Boasso, J. Nilsson, R. Zhang, N. J. Shire, S. Lindback, G. M. Shearer, and C. A. Chougnet. 2005. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 174:3143-3147. (Pubitemid 40354012)
3. Antons, A. K., R. Wang, K. Oswald-Richter, M. Tseng, C. W. Arendt, S. A. Kalams, and D. Unutmaz. 2008. Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection. J. Immunol. 180:764-773.
4. high regulatory cells in human peripheral blood. J. Immunol. 167:1245-1253. (Pubitemid 32703119)
5. Brussel, A., and P. Sonigo. 2003. Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus. J. Virol. 77:10119-10124. (Pubitemid 37122094)
6. + T-cell activation. J. Virol. 82:8307-8315.
7. + T cells by regulatory T cells during persistent retroviral infection. Immunity 20:293-303. (Pubitemid 38388231)
8. + T cell subsets that are differentially depleted during HIV infection. J. Immunol. 180:5582-5592.
9. Eggena, M. P., B. Barugahare, N. Jones, M. Okello, S. Mutalya, C. Kityo, P. Mugyenyi, and H. Cao. 2005. Depletion of regulatory T cells in HIV infection is associated with immune activation. J. Immunol. 174:4407-4414. (Pubitemid 40396024)
10. Estes, J. D., Q. Li, M. R. Reynolds, S. Wietgrefe, L. Duan, T. Schacker, L. J. Picker, D. I. Watkins, J. D. Lifson, C. Reilly, J. Carlis, and A. T. Haase. 2006. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect. Dis. 193: 703-712.
11. + regulatory T cells. Nat. Immunol. 4:330-336.
12. Grant, C., U. Oh, K. Fugo, N. Takenouchi, C. Griffith, K. Yao, T. E. Newhook, L. Ratner, and S. Jacobson. 2006. Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog. 2:e33.
13. + regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods 319:41-52.
14. Holmes, D., G. Knudsen, S. Mackey-Cushman, and L. Su. 2007. FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells. J. Biol. Chem. 282:15973-15980.
15. -/- mice in vivo. Blood 112:2858-2868.
16. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66: 2232-2239.
17. + regulatory T cells from HIV-infected individuals. Proc. Natl. Acad. Sci. USA 104:3390-3395.
18. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200:331-343.
19. + T cells in vitro. AIDS Res. Hum. Retrovir. 23:438-450.
20. + Treg cells inhibit human memory gammadelta T cells to produce IFN-gamma in response to M tuberculosis antigen ESAT-6. Blood 111:5629-5636.
21. + T cells. Nature 434:1148-1152. (Pubitemid 40663495)
22. Nilsson, J., A. Boasso, P. A. Velilla, R. Zhang, M. Vaccari, G. Franchini, G. M. Shearer, J. Andersson, and C. Chougnet. 2006. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108:3808-3817. (Pubitemid 44864563)
23. Oswald-Richter, K., S. M. Grill, N. Shariat, M. Leelawong, M. S. Sundrud, D. W. Haas, and D. Unutmaz. 2004. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2:E198.
24. Rouse, B. T., and S. Suvas. 2007. Regulatory T cells and immunity to pathogens. Expert Opin. Biol. Ther. 7:1301-1309.
25. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18-32.
26. Schuitemaker, H., M. Koot, N. A. Kootstra, M. W. Dercksen, R. E. Y. de Goede, R. P. van Steenwijk, J. M. A. Lange, J. K. M. E. Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66:1354-1360.
27. + T lymphocytes with regulatory activity. J. Immunol. 166:996-1002. (Pubitemid 32060256)
28. Selliah, N., M. Zhang, S. White, P. Zoltick, B. E. Sawaya, T. H. Finkel, and R. Q. Cron. 2008. FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity. Virology 381:161-167.
29. Shevach, E. M. 2001. Certified professionals: CD4+CD25+ suppressor T cells. J. Exp. Med. 193:F41-F46.
30. Simm, M., W. Chao, O. Pekarskaya, P. Sova, P. Gupta, R. Balachandran, and D. J. Volsky. 1996. Genetic variability and function of the long terminal repeat from syncytium-inducing and non-syncytium-inducing human immunodeficiency virus type 1. AIDS Res. Hum Retrovir. 12:801-809.
31. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969-1980.
32. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303-310.
33. Tran, T. A., M. G. de Goer de Herve, H. Hendel-Chavez, B. Dembele, E. Le Nevot, K. Abbed, C. Pallier, C. Goujard, J. Gasnault, J. F. Delfraissy, A. M. Balazuc, and Y. Taoufik. 2008. Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy. PLoS ONE 3:e3305.
34. Unutmaz, D., V. N. KewalRamani, S. Marmon, and D. R. Littman. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189:1735-1746.
35. Vetter, M. L., and R. T. D'Aquila. 2009. Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells. J. Virol. 83:8646-8654.
36. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104:3249-3256. (Pubitemid 39507143)